Anchors
| Anchor text | Ref. domains ▾ | Top DR | Ref. pages | Links to target | Dofollow links |
|---|---|---|---|---|---|
| The ASCO Post | 10 | — | 0 | 482 | 481 99.8% |
| https://ascopost.com/news/january-2026/can-kdm6a-mutations-help-guide-treatment-selection-in-bladder-cancer/ | 8 | — | 0 | 15 | 0 0% |
| ASCO Post | 5 | — | 0 | 8 | 8 100% |
| https://ascopost.com/news/january-2026/can-dna-testing-of-colorectal-polyps-improve-insight-into-genetic-risks/ | 3 | — | 0 | 3 | 0 0% |
| 3,750 young adults will die | 2 | — | 0 | 2 | 2 100% |
| study | 2 | — | 0 | 2 | 2 100% |
| You can read Dr. Sarnoff’s interview with the ASCO Post here | 2 | — | 0 | 2 | 2 100% |
| https://ascopost.com/issues/november-25-2020/use-of-pembrolizumab-in-advanced-pleural-mesothelioma-results-from-keynote-158/ | 2 | — | 0 | 2 | 2 100% |
| letter signed by 118 | 2 | — | 0 | 2 | 2 100% |
| ascopost.com | 2 | — | 0 | 2 | 2 100% |
| En savoir plus | 2 | — | 0 | 7 | 7 100% |
| Rowan Chlebowski | 2 | — | 0 | 2 | 2 100% |
| 11 | 2 | — | 0 | 2 | 0 0% |
| said | 2 | — | 0 | 2 | 1 50% |
| Prediction models for kidney failure in long-term survivors of childhood cancer | 1 | — | 0 | 1 | 1 100% |
| 1 | — | 0 | 1 | 1 100% | |
| median age of diagnosis in the 50s | 1 | — | 0 | 1 | 0 0% |
| transplants | 1 | — | 0 | 1 | 1 100% |
| ASCO Post: Sarah Price | 1 | — | 0 | 1 | 1 100% |
| Study Identifies Modifiers of Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers. | 1 | — | 0 | 1 | 1 100% |
| https://www.ascopost.com/issues/august-15-2014/high-false-positive-rate-of-elevated-cea-seen-in-patients-with-resected-colorectal-cancer/ | 1 | — | 0 | 2 | 0 0% |
| https://ascopost.com/issues/september-15-2014/fda-approves-pembrolizumab-for-advanced-melanoma/ | 1 | — | 0 | 1 | 1 100% |
| Dr. Perry died in 2011 | 1 | — | 0 | 1 | 1 100% |
| adagrasib și inhibitor EGFR | 1 | — | 0 | 1 | 1 100% |
| reverse chemotherapy resistance | 1 | — | 0 | 1 | 1 100% |
| here | 1 | — | 0 | 1 | 1 100% |
| Learn more | 1 | — | 0 | 2 | 2 100% |
| Activity of Selumetinib in Pediatric Pilocytic Astrocytoma and Low-Grade Glioma – article featured by The ASCO Post | 1 | — | 0 | 1 | 1 100% |
| Equity: Every patient. Every day. Everywhere | 1 | — | 0 | 1 | 1 100% |
| Black women have a 3.85-fold increased risk | 1 | — | 0 | 1 | 1 100% |
| https://ascopost.com/issues/february-25-2020/patient-reported-outcomes-from-imbrave150/#:~:text=Patient%2DReported%20Outcomes%20From%20IMbrave150%3A%20Better%20Quality%20of%20Life%20With%20Doublet&text=For%20the%20first%2Dline%20treatment,in%20the%20pivotal%20IMbrave150%20trial | 1 | — | 0 | 1 | 1 100% |
| https://ascopost.com/issues/june-10-2020/pembrolizumab-doubles-progression-free-survival-in-msi-hdmmr-metastatic-colorectal-cancer/ | 1 | — | 0 | 1 | 1 100% |
| https://ascopost.com/news/february-2021/have-breast-cancer-mortality-rates-stopped-declining-for-younger-women/ | 1 | — | 0 | 1 | 1 100% |
| AACR 2025: Topical BRAF Inhibitor Under Study for Managing Acneiform Rash | 1 | — | 0 | 2 | 2 100% |
| https://ascopost.com/news/january-2026/what-is-causing-a-rise-in-early-onset-gastrointestinal-cancers-including-pancreatic-cancer/?utm_source=ONC-TAP-EN-INTL-011626&utm_medium=email&md5=d70aa41f3728827bc510d0f20ff1220a | 1 | — | 0 | 1 | 1 100% |
| a median OS | 1 | — | 0 | 1 | 0 0% |
| Non–Total Body Irradiation Conditioning Regimen for Young Patients With MRD-Negative B-ALL | 1 | — | 0 | 2 | 2 100% |
| SGO | 1 | — | 0 | 1 | 1 100% |
| ASCO 2018 | 1 | — | 0 | 2 | 2 100% |
| Multigene Classifier Test for Thyroid Nodules With Indeterminate Cytology | 1 | — | 0 | 1 | 1 100% |
| ASCO Post: Urine-Based Biomarker Panel for Prostate Cancer | 1 | — | 0 | 1 | 1 100% |
| The Asco Post, online, 25.5.2022 | 1 | — | 0 | 1 | 1 100% |
| VERITAC-2 | 1 | — | 0 | 1 | 1 100% |
| https://ascopost.com/issues/june-25-2017/how-watson-for-oncology-is-advancing-personalized-patient-care/ | 1 | — | 0 | 3 | 3 100% |
| Olaparib for Germline BRCA-Mutated Metastatic Breast Cancer | 1 | — | 0 | 1 | 1 100% |
| FDA Panel Endorses Stool-Based DNA Colon Cancer Test | 1 | — | 0 | 1 | 1 100% |
| immunotherapy is indicated for | 1 | — | 0 | 1 | 1 100% |
| δημοσίευση του ASCO post | 1 | — | 0 | 1 | 0 0% |
| https://www.ascopost.com/News/59481 | 1 | — | 0 | 1 | 0 0% |
| “chromosomal rearrangements” of ALK | 1 | — | 0 | 1 | 1 100% |
Frequently Asked Questions
What anchor texts are used to link to ascopost.com?
This page shows all anchor texts found in backlinks pointing to ascopost.com, sorted by the number of referring domains using each anchor. Anchor texts range from branded terms (like the domain name itself) to keyword-rich phrases that describe the linked content. The distribution of anchor texts reveals how other websites perceive and describe ascopost.com.
What is anchor text?
Anchor text is the visible, clickable text in a hyperlink. Search engines use anchor text as a signal to understand what the linked page is about. For example, if many sites link to a page using the anchor text "best running shoes," search engines infer that the page is relevant to that topic. Anchor text appears in several forms: exact-match (contains target keywords), branded (uses the company or domain name), generic (like "click here"), and naked URLs.
Why is anchor text analysis important for SEO?
Anchor text analysis helps identify potential SEO risks and opportunities. A natural backlink profile has diverse anchor texts including branded terms, generic phrases, and topic-relevant keywords. Over-optimization, where too many backlinks use the same exact-match keyword anchor, can trigger search engine penalties. Conversely, understanding which anchors drive the most authority (measured by referring domain count and DR) helps prioritize link building efforts.
How many unique anchor texts does ascopost.com have?
The anchor text report for ascopost.com displays all distinct anchor texts grouped by their hash. Each row shows how many unique referring domains use that anchor, the total number of links, and the dofollow percentage. A high number of unique anchors generally indicates a healthy, natural backlink profile with diverse link sources.